Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Non Operating Income (2016 - 2025)

Palisade Bio has reported Non Operating Income over the past 16 years, most recently at $1.1 million for Q4 2025.

  • Quarterly Non Operating Income rose 2726.32% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 196.74% year-over-year, with the annual reading at $1.3 million for FY2025, 202.85% up from the prior year.
  • Non Operating Income was $1.1 million for Q4 2025 at Palisade Bio, up from $59000.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $11.1 million in Q3 2021 and troughed at -$317000.0 in Q1 2022.
  • The 5-year median for Non Operating Income is $139500.0 (2024), against an average of $836222.2.
  • Year-over-year, Non Operating Income surged 1110200.0% in 2021 and then plummeted 96.2% in 2022.
  • A 5-year view of Non Operating Income shows it stood at $11.1 million in 2021, then crashed by 98.85% to $128000.0 in 2022, then soared by 42.97% to $183000.0 in 2023, then tumbled by 79.23% to $38000.0 in 2024, then soared by 2726.32% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for PALI's Non Operating Income are $1.1 million (Q4 2025), $59000.0 (Q3 2025), and $59000.0 (Q2 2025).